We gleaned this information from our observations today when Benzinga's options scanner highlighted 11 extraordinary options ...
Posters presented at the 2025 American Academy of Dermatology Annual Meeting found bimekizumab to have benefits beyond safety ...
18h
IFLScience on MSNNew MERS-Related Coronavirus Discovered In Brazilian Bats – But Can It Infect Humans?Since it was first identified in 2012, the World Health Organization (WHO) says there have been a total of 2,618 confirmed ...
Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Get Free Report)’s stock price traded down 4% during trading on Thursday after ...
Arrowhead Pharmaceuticals, Inc. shines with 19 clinical programs, strategic partnerships, and promising RNAi data. Click for ...
Welcome to Maravai LifeSciences fourth quarter 2024 results earnings call. At this time, all participants are in a ...
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Alnylam Pharmaceuticals's whale activity within a strike price range from $210.0 to $340 ...
Fact(ually) strong!.
ROCKVILLE, MD, USA I March 20, 2025 I MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and ...
NuCana plc (NASDAQ: NCNA) announced financial results for the fourth quarter and year ended December 31, 2024 and provided an update on its clinical development program with its two lead anti-cancer ...
StockStory.org on MSN22h
Q4 Earnings Review: Therapeutics Stocks Led by BioMarin Pharmaceutical (NASDAQ:BMRN)As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...
The largest of the collaborations is a potentially more than $4.68 billion partnership with Shanghai-based Harbour BioMed to discover and develop next-generation multi-specific antibodies for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results